Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Antibody-drug conjugates (ADCs) are a promising class of cancer therapeutics that combine the specificity of antibodies with the cytotoxic effects of payload drugs. A quantitative understanding of how ADCs are processed intracellularly can illustrate which processing steps most influence payload delivery, thus aiding the design of more effective ADCs. In this work, we develop a kinetic model for ADC cellular processing as well as generalizable methods based on flow cytometry and fluorescence imaging to parameterize this model. | Determination of cellular processing rates for a Trastuzumab-Maytansinoid antibody-drug conjugate ADC highlights key parameters for ADC design
